Oral squamous cell carcinoma (OSCC) is a challenging disease to treat. Up to 50% of OSCC patients with advanced disease develop recurrences. Elucidation of key molecular mechanisms underlying OSCC development may provide opportunities to target specific genes and, thus, to improve patient survival. In this study, we examined the expression and functional role of interferon transmembrane protein 3 (IFITM3) in OSCC development.
The expression of IFITM3 in OSCC and normal oral mucosal tissues was assessed by qRT-PCR and immunohistochemistry. The role of IFITM3 in driving OSCC cell proliferation and survival was examined using siRNA-mediated gene knockdown, and the role of IFITM3 in driving cell cycle regulators was examined using Western blotting.
We found that IFITM3 is overexpressed in more than 79% of primary OSCCs. We also found that IFITM3 knockdown led to impaired OSCC cell growth through inhibition of cell proliferation, induction of cell cycle arrest, senescence and apoptosis. In addition, we found that IFITM3 knockdown led to reduced expressions of CCND1 and CDK4 and reduced RB phosphorylation, leading to inhibition of OSCC cell growth. This information may be instrumental for the design of novel targeted therapeutic strategies.
From our data we conclude that IFITM3 is overexpressed in OSCC and may regulate the CCND1-CDK4/6-pRB axis to mediate OSCC cell growth.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
P.M. Martensen, J. Justesen, Small ISGs coming forward. J Interf Cytokine Res 24, 1–19 (2004)
F. Siegrist, M. Ebeling, U. Certa, The small interferon-induced transmembrane genes and proteins. J Interf Cytokine Res 31, 183–197 (2011)
A.R. Everitt, S. Clare, T. Pertel, S.P. John, R.S. Wash, S.E. Smith, C.R. Chin, E.M. Feeley, J.S. Sims, D.J. Adams, H.M. Wise, L. Kane, D. Goulding, P. Digard, V. Anttila, J.K. Baillie, T.S. Walsh, D.A. Hume, A. Palotie, Y. Xue, V. Colonna, C. Tyler-Smith, J. Dunning, S.B. Gordon, R.L. Smyth, P.J. Openshaw, G. Dougan, A.L. Brass, P. Kellam, IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519–523 (2012)
A.L. Brass, I.C. Huang, Y. Benita, S.P. John, M.N. Krishnan, E.M. Feeley, B.J. Ryan, J.L. Weyer, L. van der Weyden, E. Fikrig, D.J. Adams, R.J. Xavier, M. Farzan, S.J. Elledge, The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243–1254 (2009)
S.S. Evans, R.P. Collea, J.A. Leasure, D.B. Lee, IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J Immunol 150, 736–747 (1993)
R.A. Smith, J. Young, J.J. Weis, J.H. Weis, Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun 7, 113–121 (2006)
U.C. Lange, M. Saitou, P.S. Western, S.C. Barton, M.A. Surani, The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev Biol 3, 1 (2003)
M. Saitou, B. Payer, U.C. Lange, S. Erhardt, S.C. Barton, M.A. Surani, Specification of germ cell fate in mice. Philos Trans R Soc Lond Ser B Biol Sci 358, 1363–1370 (2003)
S.S. Tanaka, G. Nagamatsu, Y. Tokitake, M. Kasa, P.P. Tam, Y. Matsui, Regulation of expression of mouse interferon-induced transmembrane protein like gene-3, Ifitm3 (mil-1, fragilis), in germ cells. Dev Dyn 230, 651–659 (2004)
S.S. Tanaka, Y.L. Yamaguchi, B. Tsoi, H. Lickert, P.P. Tam, IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion. Dev Cell 9, 745–756 (2005)
F. Yu, S.S. Ng, B.K. Chow, J. Sze, G. Lu, W.S. Poon, H.F. Kung, M.C. Lin, Knockdown of interferon-induced transmembrane protein 1 (IFITM1) inhibits proliferation, migration, and invasion of glioma cells. J Neuro-Oncol 103, 187–195 (2011)
B. Zhao, H. Wang, G. Zong, P. Li, The role of IFITM3 in the growth and migration of human glioma cells. BMC Neurol 13, 210 (2013)
H. Hatano, Y. Kudo, I. Ogawa, T. Tsunematsu, A. Kikuchi, Y. Abiko, T. Takata, IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression. Clin Cancer Res 14, 6097–6105 (2008)
D. Zhang, H. Wang, H. He, H. Niu, Y. Li, Interferon induced transmembrane protein 3 regulates the growth and invasion of human lung adenocarcinoma. Thorac Cancer 8, 337–343 (2017)
A.J. Lui, E.S. Geanes, J. Ogony, F. Behbod, J. Marquess, K. Valdez, W. Jewell, O. Tawfik, J. Lewis-Wambi, IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21. Cancer Lett 399, 29–43 (2017)
M. Yang, H. Gao, P. Chen, J. Jia, S. Wu, Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle. Oncol Rep 30, 171–178 (2013)
I.N. Sari, Y.G. Yang, L.T. Phi, H. Kim, M.J. Baek, D. Jeong, H.Y. Kwon, Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer. Oncotarget 7, 86039–86050 (2016)
F. Yu, D. Xie, S.S. Ng, C.T. Lum, M.Y. Cai, W.K. Cheung, H.F. Kung, G. Lin, X. Wang, M.C. Lin, IFITM1 promotes the metastasis of human colorectal cancer via CAV-1. Cancer Lett 368, 135–143 (2015)
P. Andreu, S. Colnot, C. Godard, P. Laurent-Puig, D. Lamarque, A. Kahn, C. Perret, B. Romagnolo, Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res 66, 1949–1955 (2006)
J. Fan, Z. Peng, C. Zhou, G. Qiu, H. Tang, Y. Sun, X. Wang, Q. Li, X. Le, K. Xie, Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: Identification and validation of IFITM3 as a biomarker of early colon carcinogenesis. Cancer 113, 266–275 (2008)
B. Tirosh, V. Daniel-Carmi, L. Carmon, A. Paz, G. Lugassy, E. Vadai, A. Machlenkin, E. Bar-Haim, M.S. Do, I.S. Ahn, M. Fridkin, E. Tzehoval, L. Eisenbach, '1-8 interferon inducible gene family': Putative colon carcinoma-associated antigens. Br J Cancer 97, 1655–1663 (2007)
D. Li, Z. Peng, H. Tang, P. Wei, X. Kong, D. Yan, F. Huang, Q. Li, X. Le, K. Xie, KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis. Clin Cancer Res 17, 3558–3568 (2011)
Y. Jia, M. Zhang, W. Jiang, Z. Zhang, S. Huang, Z. Wang, Overexpression of IFITM3 predicts the high risk of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy. PeerJ 3, e1355 (2015)
D. Borg, C. Hedner, A. Gaber, B. Nodin, R. Fristedt, K. Jirstrom, J. Eberhard, A. Johnsson, Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma. Biomark Res 4, 10 (2016)
Y. Yang, J.H. Lee, K.Y. Kim, H.K. Song, J.K. Kim, S.R. Yoon, D. Cho, K.S. Song, Y.H. Lee, I. Choi, The interferon-inducible 9-27 gene modulates the susceptibility to natural killer cells and the invasiveness of gastric cancer cells. Cancer Lett 221, 191–200 (2005)
J. Lee, S.H. Goh, N. Song, J.A. Hwang, S. Nam, I.J. Choi, A. Shin, I.H. Kim, M.H. Ju, J.S. Jeong, Y.S. Lee, Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism. Am J Pathol 181, 43–52 (2012)
J. Hu, S. Wang, Y. Zhao, Q. Guo, D. Zhang, J. Chen, J. Li, Q. Fei, Y. Sun, Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer. Oncol Rep 32, 2648–2656 (2014)
T. Hisamatsu, M. Watanabe, H. Ogata, T. Ezaki, S. Hozawa, H. Ishii, T. Kanai, T. Hibi, Interferon-inducible gene family 1-8U expression in colitis-associated colon cancer and severely inflamed mucosa in ulcerative colitis. Cancer Res 59, 5927–5931 (1999)
F. Wu, T. Dassopoulos, L. Cope, A. Maitra, S.R. Brant, M.L. Harris, T.M. Bayless, G. Parmigiani, S. Chakravarti, Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: Insights into distinctive pathogenesis. Inflamm Bowel Dis 13, 807–821 (2007)
G.S. Seo, J.K. Lee, J.I. Yu, K.J. Yun, S.C. Chae, S.C. Choi, Identification of the polymorphisms in IFITM3 gene and their association in a Korean population with ulcerative colitis. Exp Mol Med 42, 99–104 (2010)
S. Arora, A. Matta, N.K. Shukla, S.V. Deo, R. Ralhan, Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog 42, 97–108 (2005)
W. Fang, X. Li, Q. Jiang, Z. Liu, H. Yang, S. Wang, S. Xie, Q. Liu, T. Liu, J. Huang, W. Xie, Z. Li, Y. Zhao, E. Wang, F.M. Marincola, K. Yao, Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of southern China. J Transl Med 6, 32 (2008)
S.C. Cheong, G.V. Chandramouli, A. Saleh, R.B. Zain, S.H. Lau, S. Sivakumaren, R. Pathmanathan, S.S. Prime, S.H. Teo, V. Patel, J.S. Gutkind, Gene expression in human oral squamous cell carcinoma is influenced by risk factor exposure. Oral Oncol 45, 712–719 (2009)
R. Iglesias-Bartolome, D. Martin, J.S. Gutkind, Exploiting the head and neck cancer oncogenome: Widespread PI3K-mTOR pathway alterations and novel molecular targets. Cancer Discov 3, 722–725 (2013)
R.B. Zain, W.M. Ghani, I.A. Razak, R.J. Latifah, A.R. Samsuddin, S.C. Cheong, N. Abdullah, A.R. Ismail, H.B. Hussaini, N.A. Talib, A. Jallaludin, Building partnership in oral cancer research in a developing country: Processes and barriers. Asian Pac J Cancer Prev 10, 513–518 (2009)
C.P. Gan, V. Patel, C.M. Mikelis, R.B. Zain, A.A. Molinolo, M.T. Abraham, S.H. Teo, Z.A. Abdul Rahman, J.S. Gutkind, S.C. Cheong, Heterotrimeric G-protein alpha-12 (Galpha12) subunit promotes oral cancer metastasis. Oncotarget 5, 9626–9640 (2014)
S.N. Zanaruddin, A. Saleh, Y.H. Yang, S. Hamid, W.M. Mustafa, A.A. Khairul Bariah, R.B. Zain, S.H. Lau, S.C. Cheong, Four-protein signature accurately predicts lymph node metastasis and survival in oral squamous cell carcinoma. Hum Pathol 44, 417–426 (2013)
S. Hamid, K.P. Lim, R.B. Zain, S.M. Ismail, S.H. Lau, W.M. Mustafa, M.T. Abraham, N.A. Nam, S.H. Teo, S.C. Cheong, Establishment and characterization of Asian oral cancer cell lines as in vitro models to study a disease prevalent in Asia. Int J Mol Med 19, 453–460 (2007)
M.Z. Fadlullah, I.K. Chiang, K.R. Dionne, P.S. Yee, C.P. Gan, K.K. Sam, K.H. Tiong, A.K. Ng, D. Martin, K.P. Lim, T.G. Kallarakkal, W.M. Mustafa, S.H. Lau, M.T. Abraham, R.B. Zain, Z.A. Rahman, A. Molinolo, V. Patel, J.S. Gutkind, A.C. Tan, S.C. Cheong, Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies. Oncotarget 7, 27802–27818 (2016)
C.P. Gan, S. Hamid, S.Y. Hor, R.B. Zain, S.M. Ismail, W.M. Wan Mustafa, S.H. Teo, N. Saunders, S.C. Cheong, Valproic acid: Growth inhibition of head and neck cancer by induction of terminal differentiation and senescence. Head Neck 34, 344–353 (2012)
D. Szklarczyk, J.H. Morris, H. Cook, M. Kuhn, S. Wyder, M. Simonovic, A. Santos, N.T. Doncheva, A. Roth, P. Bork, L.J. Jensen, C. von Mering, The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 45, D362–D368 (2017)
P. Shannon, A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang, D. Ramage, N. Amin, B. Schwikowski, T. Ideker, Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498–2504 (2003)
A. Eldar, H. Rozenberg, Y. Diskin-Posner, R. Rohs, Z. Shakked, Structural studies of p53 inactivation by DNA-contact mutations and its rescue by suppressor mutations via alternative protein-DNA interactions. Nucleic Acids Res 41, 8748–8759 (2013)
H. Lickert, B. Cox, C. Wehrle, M.M. Taketo, R. Kemler, J. Rossant, Dissecting Wnt/beta-catenin signaling during gastrulation using RNA interference in mouse embryos. Development 132, 2599–2609 (2005)
M. Nagasawa, E.W. Gelfand, J.J. Lucas, Accumulation of high levels of the p53 and p130 growth-suppressing proteins in cell lines stably over-expressing cyclin-dependent kinase 6 (cdk6). Oncogene 20, 2889–2899 (2001)
K. Kollmann, G. Heller, C. Schneckenleithner, W. Warsch, R. Scheicher, R.G. Ott, M. Schafer, S. Fajmann, M. Schlederer, A.I. Schiefer, U. Reichart, M. Mayerhofer, C. Hoeller, S. Zochbauer-Muller, D. Kerjaschki, C. Bock, L. Kenner, G. Hoefler, M. Freissmuth, A.R. Green, R. Moriggl, M. Busslinger, M. Malumbres, V. Sexl, A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell 30, 359–360 (2016)
J.J. Lucas, J. Domenico, E.W. Gelfand, Cyclin-dependent kinase 6 inhibits proliferation of human mammary epithelial cells. Mol Cancer Res 2, 105–114 (2004)
C.R. Pickering, J. Zhang, S.Y. Yoo, L. Bengtsson, S. Moorthy, D.M. Neskey, M. Zhao, M.V. Ortega Alves, K. Chang, J. Drummond, E. Cortez, T.X. Xie, D. Zhang, W. Chung, J.P. Issa, P.A. Zweidler-McKay, X. Wu, A.K. El-Naggar, J.N. Weinstein, J. Wang, D.M. Muzny, R.A. Gibbs, D.A. Wheeler, J.N. Myers, M.J. Frederick, Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov 3, 770–781 (2013)
T.N. Beck, E.A. Golemis, Genomic insights into head and neck cancer. Cancers of the head & neck 1, (2016). https://doi.org/10.1186/s41199-016-0003-z
T.C.G.A. Network, M.S. Lawrence, C. Sougnez, L. Lichtenstein, K. Cibulskis, E. Lander, S.B. Gabriel, G. Getz, A. Ally, M. Balasundaram, I. Birol, R. Bowlby, D. Brooks, Y.S.N. Butterfield, R. Carlsen, D. Cheng, A. Chu, N. Dhalla, R. Guin, R.A. Holt, S.J.M. Jones, D. Lee, H.I. Li, M.A. Marra, M. Mayo, R.A. Moore, A.J. Mungall, A.G. Robertson, J.E. Schein, P. Sipahimalani, A. Tam, N. Thiessen, T. Wong, A. Protopopov, N. Santoso, S. Lee, M. Parfenov, J. Zhang, H.S. Mahadeshwar, J. Tang, X. Ren, S. Seth, P. Haseley, D. Zeng, L. Yang, A.W. Xu, X. Song, A. Pantazi, C.A. Bristow, A. Hadjipanayis, J. Seidman, L. Chin, P.J. Park, R. Kucherlapati, R. Akbani, T. Casasent, W. Liu, Y. Lu, G. Mills, T. Motter, J. Weinstein, L. Diao, J. Wang, Y.H. Fan, J. Liu, K. Wang, J.T. Auman, S. Balu, T. Bodenheimer, E. Buda, D.N. Hayes, K.A. Hoadley, A.P. Hoyle, S.R. Jefferys, C.D. Jones, P.K. Kimes, Y. Liu, J.S. Marron, S. Meng, P.A. Mieczkowski, L.E. Mose, J.S. Parker, C.M. Perou, J.F. Prins, J. Roach, Y. Shi, J.V. Simons, D. Singh, M.G. Soloway, D. Tan, U. Veluvolu, V. Walter, S. Waring, M.D. Wilkerson, J. Wu, N. Zhao, A.D. Cherniack, P.S. Hammerman, A.D. Tward, C.S. Pedamallu, G. Saksena, J. Jung, A.I. Ojesina, S.L. Carter, T.I. Zack, S.E. Schumacher, R. Beroukhim, S.S. Freeman, M. Meyerson, J. Cho, L. Chin, G. Getz, M.S. Noble, D. DiCara, H. Zhang, D.I. Heiman, N. Gehlenborg, D. Voet, P. Lin, S. Frazer, P. Stojanov, Y. Liu, L. Zou, J. Kim, C. Sougnez, S.B. Gabriel, M.S. Lawrence, D. Muzny, H. Doddapaneni, C. Kovar, J. Reid, D. Morton, Y. Han, W. Hale, H. Chao, K. Chang, J.A. Drummond, R.A. Gibbs, N. Kakkar, D. Wheeler, L. Xi, G. Ciriello, M. Ladanyi, W. Lee, R. Ramirez, C. Sander, R. Shen, R. Sinha, N. Weinhold, B.S. Taylor, B.A. Aksoy, G. Dresdner, J. Gao, B. Gross, A. Jacobsen, B. Reva, N. Schultz, S.O. Sumer, Y. Sun, T.A. Chan, L.G. Morris, J. Stuart, S. Benz, S. Ng, C. Benz, C. Yau, S.B. Baylin, L. Cope, L. Danilova, J.G. Herman, M. Bootwalla, D.T. Maglinte, P.W. Laird, T. Triche Jr., D.J. Weisenberger, D.J. Van Den Berg, N. Agrawal, J. Bishop, P.C. Boutros, J.P. Bruce, L.A. Byers, J. Califano, T.E. Carey, Z. Chen, H. Cheng, S.I. Chiosea, E. Cohen, B. Diergaarde, A.M. Egloff, A.K. El-Naggar, R.L. Ferris, M.J. Frederick, J.R. Grandis, Y. Guo, R.I. Haddad, P.S. Hammerman, T. Harris, D.N. Hayes, A.B.Y. Hui, J.J. Lee, S.M. Lippman, F.-F. Liu, J.B. McHugh, J. Myers, P.K.S. Ng, B. Perez-Ordonez, C.R. Pickering, M. Prystowsky, M. Romkes, A.D. Saleh, M.A. Sartor, R. Seethala, T.Y. Seiwert, H. Si, A.D. Tward, C. Van Waes, D.M. Waggott, M. Wiznerowicz, W.G. Yarbrough, J. Zhang, Z. Zuo, K. Burnett, D. Crain, J. Gardner, K. Lau, D. Mallery, S. Morris, J. Paulauskis, R. Penny, C. Shelton, T. Shelton, M. Sherman, P. Yena, A.D. Black, J. Bowen, J. Frick, J.M. Gastier-Foster, H.A. Harper, K. Leraas, T.M. Lichtenberg, N.C. Ramirez, L. Wise, E. Zmuda, J. Baboud, M.A. Jensen, A.B. Kahn, T.D. Pihl, D.A. Pot, D. Srinivasan, J.S. Walton, Y. Wan, R.A. Burton, T. Davidsen, J.A. Demchok, G. Eley, M.L. Ferguson, K.R.M. Shaw, B.A. Ozenberger, M. Sheth, H.J. Sofia, R. Tarnuzzer, Z. Wang, L. Yang, J.C. Zenklusen, C. Saller, K. Tarvin, C. Chen, R. Bollag, P. Weinberger, W. Golusiński, P. Golusiński, M. Ibbs, K. Korski, A. Mackiewicz, W. Suchorska, B. Szybiak, M. Wiznerowicz, K. Burnett, E. Curley, J. Gardner, D. Mallery, R. Penny, T. Shelton, P. Yena, C. Beard, C. Mitchell, G. Sandusky, N. Agrawal, J. Ahn, J. Bishop, J. Califano, Z. Khan, J.P. Bruce, A.B.Y. Hui, J. Irish, F.-F. Liu, B. Perez-Ordonez, J. Waldron, P.C. Boutros, D.M. Waggott, J. Myers, W.N. William Jr., S.M. Lippman, S. Egea, C. Gomez-Fernandez, L. Herbert, C.R. Bradford, T.E. Carey, D.B. Chepeha, A.S. Haddad, T.R. Jones, C.M. Komarck, M. Malakh, J.B. McHugh, J.S. Moyer, A. Nguyen, L.A. Peterson, M.E. Prince, L.S. Rozek, M.A. Sartor, E.G. Taylor, H.M. Walline, G.T. Wolf, L. Boice, B.S. Chera, W.K. Funkhouser, M.L. Gulley, T.G. Hackman, D.N. Hayes, M.C. Hayward, M. Huang, W.K. Rathmell, A.H. Salazar, W.W. Shockley, C.G. Shores, L. Thorne, M.C. Weissler, S. Wrenn, A.M. Zanation, S.I. Chiosea, B. Diergaarde, A.M. Egloff, R.L. Ferris, M. Romkes, R. Seethala, B.T. Brown, Y. Guo, M. Pham, W.G. Yarbrough, Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576–582 (2015)
L. Michel, J. Ley, T.M. Wildes, A. Schaffer, A. Robinson, S.E. Chun, W. Lee, J. Lewis Jr., K. Trinkaus, D. Adkins, Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. Oral Oncol 58, 41–48 (2016)
We would like to thank all consented patients who participated in this study. This study was funded by Ministry of Science, Technology and Innovation (MOSTI 06-00-00-0000), University of Malaya (UM.C/625/1/HIR/MOHE/DENT-03) and sponsors of Cancer Research Malaysia. Cancer Research Malaysia is a non-profit research organization. We are committed to an understanding of cancer prevention, diagnosis and treatment through a fundamental research program.
Conflict of interest
All authors declared that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Gan, C.P., Sam, K.K., Yee, P.S. et al. IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells. Cell Oncol. 42, 477–490 (2019). https://doi.org/10.1007/s13402-019-00437-z
- Oral squamous cell carcinoma